Bengaluru, India. — September 7, 2026 — HeyVoli, a company previously known for its generative AI platform, announced today that it is shifting its focus to building AI infrastructure for healthcare systems. The company said its new direction aims to address fragmentation in healthcare technology by creating a layer that connects data, workflows, and intelligence across existing systems.
The transition marks a strategic pivot from offering standalone AI tools to developing an architecture that supports interoperability and coordination across the healthcare ecosystem. HeyVoli said its platform is designed to work alongside current systems rather than replace them, targeting hospitals, laboratories, pharmacies, insurers, and other stakeholders.
According to the company, the new infrastructure includes several components: CoreK, an intelligent systems layer for data and workflow integration; CareOS, for patient experience; FlowGrid, for operational workflows; SignalNet, for real-time signals; and TwinMind, for decision support. These are intended to enable AI to operate with proper context, permissions, and governance.
The announcement comes as healthcare organizations increasingly adopt AI but face challenges with data silos and interoperability. HeyVoli cited global efforts, such as India's Unified Health Interface, as examples of the push toward connected digital health infrastructure.
HeyVoli said its long-term goal is to help healthcare organizations move from fragmented technology environments to more coordinated and observable systems. The company did not disclose specific product launch dates or financial details.
HeyVoli is a technology company focused on AI infrastructure for healthcare. For more information, visit www.heyvoli.com.
The healthcare industry has long struggled with interoperability, as patient data often resides in disparate electronic health record (EHR) systems, laboratory information systems, and pharmacy databases that do not communicate seamlessly. This fragmentation leads to inefficiencies, increased costs, and potential risks to patient safety. By positioning itself as an infrastructure provider, HeyVoli aims to create a unified layer that can aggregate and harmonize data from various sources, enabling AI applications to access comprehensive and up-to-date information.
HeyVoli's pivot reflects a broader trend in the technology sector, where companies are moving from point solutions to platform-based approaches that can support multiple use cases. In healthcare, this shift is particularly relevant as providers seek to leverage AI for predictive analytics, personalized medicine, and operational optimization. However, the success of such initiatives depends on the availability of clean, well-governed data, which HeyVoli's infrastructure intends to facilitate.
The company's components are designed to address different aspects of healthcare operations. CoreK serves as the backbone, integrating data from various sources and ensuring that workflows are streamlined. CareOS focuses on patient engagement, providing tools for appointment scheduling, communication, and access to health records. FlowGrid aims to optimize hospital operations, such as patient flow and resource allocation. SignalNet provides real-time alerts and monitoring, while TwinMind offers clinical decision support to healthcare professionals.
HeyVoli's emphasis on governance and permissions is critical in the healthcare sector, where data privacy and security are paramount. By building these considerations into its infrastructure, the company aims to ensure that AI applications comply with regulations like HIPAA in the United States and GDPR in Europe.
The reference to India's Unified Health Interface (UHI) highlights the global movement towards open, interoperable health systems. UHI is an initiative by the Indian government to create a digital health ecosystem that allows different health applications to interact seamlessly. HeyVoli sees its platform as complementary to such efforts, providing a layer that can adapt to various national and regional standards.
While HeyVoli has not provided a timeline for product releases, the company's strategic shift is likely to attract attention from healthcare providers and investors alike. As the demand for AI in healthcare grows, the need for robust infrastructure becomes increasingly evident. HeyVoli's move positions it to capitalize on this trend, offering a solution that addresses the root causes of fragmentation rather than merely treating the symptoms.
In the coming months, industry observers will be watching to see how HeyVoli executes its vision and whether it can differentiate itself in a competitive market. The company's success will depend on its ability to forge partnerships with healthcare organizations and technology vendors, as well as its capacity to deliver on its promises of interoperability and governance. For now, HeyVoli's announcement marks a significant step in its evolution and a potential catalyst for change in healthcare technology.